New Procedure Offers Solution to Weight Rebound After GLP-1 Drug Discontinuation
Rapid Read

New Procedure Offers Solution to Weight Rebound After GLP-1 Drug Discontinuation

What's Happening? A new clinical trial has introduced a minimally invasive procedure called duodenal mucosal resurfacing, which may help individuals maintain weight loss after discontinuing GLP-1 drugs. These drugs, including Ozempic, Wegovy, and Mounjaro, are widely used for diabetes management and
Summarized by AI
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.